TNFRSF10D Antibody (C-term) western blot analysis in CEM cell line lysates (35ug/lane).This demonstrates the TNFRSF10D antibody detected the TNFRSF10D protein (arrow).
TNFRSF10D; DCR2; TRAILR4; TRUNDD; Tumor necrosis factor receptor superfamily member 10D; Decoy receptor 2; TNF-related apoptosis-inducing ligand receptor 4; TRAIL receptor with a truncated death domain; CD_antigen=CD264; Flags: Precursor
Key Feature
Clonality
Polyclonal
Isotype
Ig
Host Species
Rabbit
Tested Applications
WB
WB:1:100~500
Species Reactivity
Human
Concentration
1mg/ml
Target Information
Gene Synonyms
DCR2 TRAILR4 TRUNDD
Alternative Names
TNFRSF10D DCR2 TRAILR4 TRUNDD Tumor necrosis factor receptor superfamily member 10D Decoy receptor 2 TNF-related apoptosis-inducing ligand receptor 4 TRAIL receptor with a truncated death domain CD_antigen=CD264 Flags: Precursor
Molecular Weight(MW)
41823 Da
Function
Receptor for the cytotoxic ligand TRAIL. Contains a truncated death domain and hence is not capable of inducing apoptosis but protects against TRAIL-mediated apoptosis. Reports are contradictory with regards to its ability to induce the NF- kappa-B pathway. According to PubMed:9382840, it cannot but according to PubMed:9430226, it can induce the NF-kappa-B pathway
Tissue Specificity
Widely expressed, in particular in fetal kidney, lung and liver, and in adult testis and liver. Also expressed in peripheral blood leukocytes, colon and small intestine, ovary, prostate, thymus, spleen, pancreas, kidney, lung, placenta and heart
TNFRSF10D Antibody (C-term) western blot analysis in CEM cell line lysates (35ug/lane).This demonstrates the TNFRSF10D antibody detected the TNFRSF10D protein (arrow).
Application Notes
WB:1:100~500
Additional Information
Form
Liquid
Storage Instructions
For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Storage Buffer
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.